Literature DB >> 24265271

Acceptance and Commitment Therapy for the Treatment of Posttraumatic Stress Among Adolescents.

Michelle R Woidneck1, Kate L Morrison2, Michael P Twohig2.   

Abstract

The number of individuals who meet diagnostic criteria for posttraumatic stress disorder (PTSD) is a small percentage of those exposed to trauma; many youth who do not meet criteria for PTSD continue to experience problematic posttraumatic stress (PTS) symptomology. Acceptance and commitment therapy (ACT) has shown preliminary effectiveness in the treatment of adult PTSD, but its effectiveness in treating PTS in youth is unknown. Using a multiple-baseline design, this study investigated the effectiveness of 10 weeks of ACT to treat PTS in youth. Four adolescents from a community sample and three adolescents from a residential sample participated. The Clinician Administered PTSD Scale for Children and Adolescents (CAPS-CA), Child PTSD Symptom Scale (CPSS), and Comprehensive Quality of Life Scale were completed at pretreatment, posttreatment, and 3-month follow-up. Individuals reported baseline data for 7 to 66 days. Symptom and process measures were completed at each session. Results revealed a decrease in PTS symptomology across both samples with mean reductions in self-reported PTS symptomology at posttreatment of 69% and 81% for the community and residential samples, respectively, and an overall 68% and 84% respective reduction at follow-up. Reductions in clinician rated measures of PTSD were observed for all participants with mean reductions of 57% and 61% in the community and residential samples at posttreatment, and 71% and 60% at follow-up, respectively. Results provide preliminary support for ACT as a treatment for adolescent PTS. Empirical and clinical implications as well as limitations and future directions are discussed.
© The Author(s) 2013.

Entities:  

Keywords:  PTS; PTSD; acceptance and commitment therapy; treatment

Mesh:

Year:  2013        PMID: 24265271     DOI: 10.1177/0145445513510527

Source DB:  PubMed          Journal:  Behav Modif        ISSN: 0145-4455


  5 in total

1.  Mindfulness-Based Stress Reduction (MBSR) as a Standalone Intervention for Posttraumatic Stress Disorder after Mixed Traumatic Events: A Mixed-Methods Feasibility Study.

Authors:  Meike Müller-Engelmann; Susanne Wünsch; Marina Volk; Regina Steil
Journal:  Front Psychol       Date:  2017-09-05

2.  Investigating the effectiveness of an online acceptance and commitment therapy (ACT) intervention versus a waiting list control condition on pain interference and quality of life in adults with chronic pain and multimorbidity: protocol for a randomised controlled trial.

Authors:  Brian W Slattery; Laura L O'Connor; Stephanie Haugh; Katie Barrett; Kady Francis; Christopher P Dwyer; Siobhan O'Higgins; Line Caes; Jonathan Egan; Brian E McGuire
Journal:  BMJ Open       Date:  2019-05-09       Impact factor: 2.692

3.  Unified Protocol for Transdiagnostic Prevention of Depression and Anxiety in Iranian Adolescents: Protocol Development and Initial Outcome Data.

Authors:  Abolfazl Mohammadi; Mehdi Soleimani; Mohammad Reza Mohammadi; Imaneh Abasi; Ali Akbar Foroughi
Journal:  Iran J Psychiatry       Date:  2019-04

4.  The ACTyourCHANGE in Teens Study Protocol: An Acceptance and Commitment Therapy-Based Intervention for Adolescents with Obesity: A Randomized Controlled Trial.

Authors:  Anna Guerrini Usubini; Roberto Cattivelli; Vanessa Bertuzzi; Giorgia Varallo; Alessandro Alberto Rossi; Clarissa Volpi; Michela Bottacchi; Sofia Tamini; Alessandra De Col; Giada Pietrabissa; Stefania Mannarini; Gianluca Castelnuovo; Enrico Molinari; Alessandro Sartorio
Journal:  Int J Environ Res Public Health       Date:  2021-06-09       Impact factor: 3.390

5.  Inflexible Youngsters: Psychological and Psychopathological Correlates of the Avoidance and Fusion Questionnaire for Youths in Nonclinical Dutch Adolescents.

Authors:  Peter Muris; Cor Meesters; Anke Herings; Marieke Jansen; Chris Vossen; Pina Kersten
Journal:  Mindfulness (N Y)       Date:  2017-03-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.